1 / 6

Electrophysiology Devices Market Size, Share & Trends Analysis Report by 2020

Electrophysiology Devices Market Analysis By Application (Cardiac Resynchronization Therapy, Holter Monitoring Devices, Electroretinograph, Electrocardiograph, Diagnostic Electrophysiology Catheters, Imaging and 3D Mapping Systems, Electroencephalograph, Electromyograph, X-Ray, Electrocorticograph, Electrooculograph, Pacemakers, Implantable Cardioverter Defibrillators) And Segment Forecasts To 2020

Marsh
Download Presentation

Electrophysiology Devices Market Size, Share & Trends Analysis Report by 2020

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Electrophysiology Devices Market Analysis, Size, Growth, Share & Forecast to 2020 | Grand View Research Inc. “Electrophysiology devices market to grow at a CAGR of 5.0% from 2014 to 2020” Electrophysiology Devices Industry is anticipated to grow at a CAGR of over 5.0% and reach over USD 6.18 billion by 2020 owing to growing old age population and frequent cardiac arrhythmias incidents. Adoption of ablation and diagnostics techniques among physicians has resulted in increased usage of the product in the past few years and is likley to drive market growth. Development of new devices such as nanostimleadless pacemaker is also anticipated to fuel demand in the market. Catherer ablation has gained popularity as the first line treatment, rendering 95.0% success rate for several rhythm disorders and is anticipated to be a key driving factor for growth. Diagnostic electrophysiology catheters are estimated to grow at the CAGR of over 15.0% in the foreseeable future.Technological developments such as laser ablation, cryo-ablation and ultrasound ablation, coupled with optimised mapping techniques are anticipated to augment market growth over the forecast period. Electrophysiology treatment & monitoring devices contributed to a share of over 60.0% of in 2013. X-ray systems was the most widely used device in electrophysiology monitoring sector. Market growth can be attributed to improving diagnostic interventional capabilities of healthcare consultants and increasing usage of digital and portable systems. Technological improvements such as Optima IGS 320 and GE Healthcare’s Innova IGS 520 are projected to provide future opportunities for growth. These are dose efficient products and interventional X-ray systems that allow physicians to perform compound interventional procedures with accuracy and ease. Electrophysiology treatment devices include pacemakers, implantable cardioverter defibrillators (ICD) and catheters. Catheters emerged as the largest treatment devices segment in 2013 owing to growing number of interventional procedures and extensive usage of treatment devices in electrophysiology readings. However, Follow Us:

  2. rising costs related with the product, existence of strict regulations and accessibility of substitute therapies are anticipated to hamper growth over the forecast period. In 2013, North America contributed to over 30.0% of the overall market share and emerged as the dominant market owing to frequent occurrence of cardiac arrhythmia resulting from unhealthy lifestyle habits. Increasing demand for the latest healthcare infrastructure and rising consumer awareness are anticipated to propel growth. Asia-Pacific is a lucrative market owing to high rate of unmet medical requirements leading to increase in the number of patients. Rapid developments in healthcare infrastructure and increase in disposable income in emerging economies such as India and China are expected to provide new avenues and opportunities for companies to capitalize over the forecast period. Key electrophysiology device manufacturers include Biotronik SE & Co. KG, Medtronic Inc., St. Jude Medical, Boston Scientific Corporation and Abbott Laboratories. Browse Details of Report @ http://www.grandviewresearch.com/industry-analysis/electrophysiology- devices-market Table of Content Chapter 1. Executive Summary 1.1. Electrophysiology Devices - Industry Summary and Critical Success Factors (CSFs) Chapter 2. Electrophysiology Devices Industry Outlook 2.1. Market Segmentation 2.2. Market Size and Growth Prospects 2.3. Electrophysiology Devices Market Dynamics 2.3.1. Market Driver Analysis 2.3.2. Market Restraint Analysis 2.4. Key Opportunities Prioritized 2.5. Industry Analysis - Porter's 2.6. Electrophysiology Devices - Company Market Share Analysis 2.7. Electrophysiology Devices Market PESTEL Analysis, 2012 Chapter 3. Electrophysiology Devices Application Outlook 3.1. Electrophysiology Treatment Devices 3.1.1. Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.2. CRT Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.3. Catheters Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.1.4. Pacemakers Market Estimates and Forecasts, 2012 - 2020 (USD Million) Follow Us:

  3. 3.1.5. ICD Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2. Electrophysiology Monitoring Devices 3.2.1. Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.2. Holter Monitoring Devices Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.3. ERG Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.4. Diagnostic Catheters Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.5. ECG Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.6. Imaging & 3D Mapping Systems Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.7. EEG Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.8. EMG Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.9. X-Ray Systems Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.10. ECOG Market Estimates and Forecasts, 2012 - 2020 (USD Million) 3.2.11. EOG Market Estimates and Forecasts, 2012 - 2020 (USD Million) Chapter 4. Electrophysiology Devices Regional Outlook 4.1. North America 4.1.1. Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.1.2. U.S. Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.1.3. Canada Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.2. Europe 4.2.1. Europe Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.2.2. France Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.2.3. Spain Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.2.4. Germany Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.3. Asia Pacific 4.3.1. Asia Pacific Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.3.2. India Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.3.3. China Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.3.4. Japan Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.4. RoW 4.4.1. RoW Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) 4.4.2. Brazil Market Estimates and Forecasts, by Application, 2012 - 2020 (USD Million) Chapter 5 Electrophysiology Devices Competitive Landscape 5.1 Siemens Healthcare Follow Us:

  4. 5.1.1 Company Overview 5.1.2 Financial Performance 5.1.3 Product Benchmarking 5.1.4 Strategic Initiatives 5.2 Boston Scientific 5.2.1 Company Overview 5.2.2 Financial Performance 5.2.3 Product Benchmarking 5.2.4 Strategic Initiatives 5.3 St. Jude Medical, Inc. 5.3.1 Company Overview 5.3.2 Financial Performance 5.3.3 Product Benchmarking 5.3.4 Strategic Initiatives 5.4 Medtronic Inc. 5.4.1 Company Overview 5.4.2 Financial Performance 5.4.3 Product Benchmarking 5.4.4 Strategic Initiatives 5.5 Biotronik SE & Co. KG 5.5.1 Company Overview 5.5.2 Financial Performance 5.5.3 Product Benchmarking 5.5.4 Strategic Initiatives 5.6 Abbott Laboratories 5.6.1 Company Overview 5.6.2 Financial Performance 5.6.3 Product Benchmarking 5.6.4 Strategic Initiatives 5.7 Johnson & Johnson 5.7.1 Company Overview 5.7.2 Financial Performance 5.7.3 Product Benchmarking 5.7.4 Strategic Initiatives Follow Us:

  5. 5.8 Nihon Kohden Corporation 5.8.1 Company Overview 5.8.2 Financial Performance 5.8.3 Product Benchmarking 5.8.4 Strategic Initiatives 5.9 GE Healthcare 5.9.1 Company Overview 5.9.2 Financial Performance 5.9.3 Product Benchmarking 5.9.4 Strategic Initiatives 5.10 Philips Healthcare 5.10.1 Company Overview 5.10.2 Financial Performance 5.10.3 Product Benchmarking 5.10.4 Strategic Initiatives 5.11 MicroPort Scientific Corporation 5.11.1 Company Overview 5.11.2 Financial Performance 5.11.3 Product Benchmarking 5.11.4 Strategic Initiatives Chapter 6. Methodology and Scope 6.1. Research Methodology 6.2. Research Scope & Assumption 6.3. List of Data Sources Follow Us:

  6. About Grand View Research, Inc.: Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, the company offers market intelligence studies ensuring relevant and fact-based research across a range of industries including technology, chemicals, materials, healthcare and energy. Contact: Sherry James Corporate Sales Specialist, USA Grand View Research, Inc Phone: 1-415- 349-0058 Toll Free: 1-888- 202-9519 Email:sales@grandviewresearch.com For More Information:https://www.grandviewresearch.com Follow Us:

More Related